Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

BACKGROUND: Estrogen receptor (ER) positive breast cancer can often be treated by hormone therapy; however a certain population of ER-positive patients become resistant to hormone therapy after long-term hormone treatment. Ethinylestradiol (EE2) is a derivative of estrogen, which has shown promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Omoto, Yoko, Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Hayashi, Mitsuhiro, Sueta, Aiko, Fujiwara, Saori, Taguchi, Tetsuya, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353819/
https://www.ncbi.nlm.nih.gov/pubmed/25774336
http://dx.doi.org/10.1186/s40064-015-0851-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353819/
https://www.ncbi.nlm.nih.gov/pubmed/25774336
http://dx.doi.org/10.1186/s40064-015-0851-8

Ejemplares similares